The fact that they eat a lot – and often – may explain why most people and other mammals are protected from the majority of fungal pathogens, according to research from Albert Einstein College of Medicine of Yeshiva University.
Lynne Holden, M.D., associate professor of clinical emergency medicine at Albert Einstein College of Medicine of Yeshiva University, has been named a Robert Wood Johnson Foundation Community Health Leader (CHL) for her work with Mentoring in Medicine. Dr. Holden is co-founder and president of the organization, which encourages disadvantaged students to enter the health professions. Dr. Holden is one of 10 honorees who received the CHL Award at a ceremony held in the Mayflower Hotel in Washington, D.C. earlier today.
Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.
The National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University a four-year, $7.2 million grant to develop a microbicide-releasing vaginal ring to prevent HIV transmission.
The Department of Health and Human Services (HHS) has awarded Albert Einstein College of Medicine of Yeshiva University a three-year, $2.1 million grant to expand and enrich its Hispanic Center of Excellence (HCOE).
An innovative drug-delivery system – nanoparticles encapsulating nitric oxide or prescription drugs – shows promise for topical treatment of erectile dysfunction (ED), according to a new study by scientists at Albert Einstein College of Medicine of Yeshiva University.
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University two grants totaling $3.5 million to study epigenetic changes — chemical modifications of genes caused by stress, diet or other environmental influences — and how they contribute to human diseases and biological processes.
Researchers at Albert Einstein College of Medicine of Yeshiva University have identified two small protein fragments that could be developed into an anthrax vaccine that may cause fewer side effects than the current vaccine.
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $11.2 million grant to study the impact of damage to DNA on aging and disease.
Researchers at Albert Einstein College of Medicine of Yeshiva University have linked areas of brain injury to specific altered mental processes caused by concussions.
The deadliest part of the cancer process, metastasis, appears to rely on help from macrophages, potent immune system cells that usually defend vigorously against disease, researchers at Albert Einstein College of Medicine of Yeshiva University report. The deadliest part of the cancer process, metastasis, appears to rely on help from macrophages, potent immune system cells that usually defend vigorously against disease, researchers at Albert Einstein College of Medicine of Yeshiva University report.
Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study of over 6,000 children by researchers at Albert Einstein College of Medicine of Yeshiva University.
A cellular protein that may prevent nerve cells from dying also helps to improve insulin action and lower blood glucose levels, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University in collaboration with scientists at University of California, Los Angeles (UCLA).
The National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $10 million grant to study how the motion of atoms on both extremely small and long time scales contribute to enzyme function.
Elevated insulin levels in the blood appear to raise the risk of breast cancer in postmenopausal women, according to researchers at Albert Einstein College of Medicine of Yeshiva University.
New research published in Journal of Infectious Diseases highlights a new lab test that better predicts microbicide safety. Research at Albert Einstein College of Medicine explains why several once-promising microbicides have failed.
Allen M. Spiegel, M.D., The Marilyn and Stanley M. Katz Dean of Albert Einstein College of Medicine of Yeshiva University, has been appointed by Governor David Paterson to the Empire State Stem Cell Board Funding Committee.
A variation in a gene that is active in the central nervous system is associated with increased risk for obesity, according to an international study in which Albert Einstein College of Medicine of Yeshiva University played a major role. The research adds to evidence that genes influence appetite and that the brain plays a key role in obesity.
Solomon L. Moshé, M.D., a leading pediatric epilepsy clinician and researcher at Albert Einstein College of Medicine of Yeshiva University, will become the new elected President of the International League Against Epilepsy (ILAE) on July 2nd at the International Epilepsy Congress in Budapest, Hungary.
The capability and scope of magnetic resonance imaging (MRI) studies at Albert Einstein College of Medicine of Yeshiva University are being significantly expanded with the appointment of two nationally recognized leaders in the field. Craig Branch, Ph.D., has been named director, and Michael Lipton, M.D., Ph.D., has been named associate director of Einstein's Gruss Magnetic Resonance Research Center (MRRC). Both are faculty in the department of radiology, which will manage the center under the guidance of its chair, Dr. Stephen Amis.
Prominent stem cell and dry eye researcher Roy S. Chuck, M.D., Ph.D., has been appointed chair of ophthalmology and visual sciences at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein.
In a study published in The Journal of Infectious Diseases, researchers from Albert Einstein College of Medicine of Yeshiva University have identified cells in blood that predict which HIV-positive individuals are most likely to develop deadly fungal meningitis, a major cause of HIV-related death. This form of meningitis affects more than 900,000 HIV-infected people globally"”most of them in sub-Saharan Africa and other areas of the world where antiretroviral therapy for HIV is not available.
The National Institute on Drug Abuse of the National Institutes of Health has awarded a three-year, $3-million grant to Albert Einstein College of Medicine of Yeshiva University to establish a research center to study the neurological complications that afflict people infected with HIV, the virus that causes AIDS.
A consortium of research centers in the Tri-state Region, including Albert Einstein College of Medicine of Yeshiva University, has received a $46 million grant to conduct research on emerging infectious diseases.
Eating red or white meat, including meat cooked at high temperatures, does not increase the risk of breast cancer in postmenopausal women, according to a large study conducted by researchers at Albert Einstein College of Medicine of Yeshiva University.
Fifty years after the first graduating class of Albert Einstein College of Medicine of Yeshiva University received their degrees, the College of Medicine will confer more than 200 diplomas during its 2009 commencement ceremony.
On the occasion of the 50th anniversary of its first graduating class, Albert Einstein College of Medicine of Yeshiva University will welcome Elizabeth G. Nabel, M.D., director of the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, to deliver the 2009 commencement address.
Jonathan R. Lai, Ph.D., assistant professor of biochemistry at Albert Einstein College of Medicine of Yeshiva University, has been awarded the Arnold and Mabel Beckman Foundation's 2009 Young Investigator Award.
Scientists at Albert Einstein College of Medicine of Yeshiva University have discovered how a gene crucial in triggering the spread of breast cancer is turned on and off. The findings could help predict whether breast tumors will metastasize and also reveal potential drug targets for preventing metastasis. The study will appear in the May 20th online edition of the Journal of Cell Science.
Inappropriate use of camphor-containing products may be a common and underappreciated cause of seizures in young children, according to a new study by researchers at Albert Einstein College of Medicine of Yeshiva University. The study, published in this month's issue of Pediatrics, calls for efforts to educate communities about the hazards of camphor and to crack down on illegally marketed camphor products.
Scientists at Albert Einstein College of Medicine of Yeshiva University have combined their revolutionary new drug-delivery system with a powerful antimicrobial agent to treat potentially deadly drug-resistant staph infections in mice. The study is published this month in the online version of the Journal of Investigative Dermatology.
A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck.
Recurrent and metastatic endometrial and ovarian cancers can be notoriously difficult to treat: They have spread to other organs and typically have developed resistance to chemotherapy; and patients already heavily treated with chemotherapy may not be able to endure more chemo. Now, physicians at Albert Einstein College of Medicine of Yeshiva University have shown that a combination of two chemotherapy drugs not only produced clinical benefit for such patients but were also well tolerated.
Scientists at Albert Einstein College of Medicine of Yeshiva University have developed a simple, accurate, and highly sensitive test to detect and quantify ricin, an extremely potent toxin with potential use as a bioterrorism agent. The report appears as a featured article in the April 12th issue of Analytical Chemistry.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a process that controls the amount of fat that cells store for use as a back-up energy source. Disruption of this process allows cellular fat to accumulate "” a key factor in age-related metabolic diseases such as obesity and type 2 diabetes.
Scientists at Albert Einstein College of Medicine of Yeshiva University have proposed a sweeping new theory of autism that suggests that the brains of people with autism are structurally normal but dysregulated, meaning symptoms of the disorder might be reversible.
Scientists at the Albert Einstein College of Medicine of Yeshiva University have previously shown that the co-mingling of three cell types can predict whether localized breast cancer will spread throughout the body. Their new collaboration with other scientists has led to a test with potential clinical application for precisely identifying which patients should receive aggressive therapy "” sparing many women at low risk for metastatic disease from undergoing unnecessary and potentially dangerous treatment.
The National Institute of Child Health and Development (NICHD) of the National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University a $7.5 million grant to establish a Specialized Cooperative Center Program in Reproduction and Infertility Research (SCCPIR).
Researchers from the Albert Einstein College of Medicine and The University of Pittsburgh have developed an onsite method to quickly diagnose tuberculosis (TB) and expose the deadly drug-resistant strains that can mingle undetected with treatable TB strains.
A groundbreaking partnership between the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN) in South Africa will establish an international research center focused on making major scientific contributions to the worldwide effort to control the devastating co-epidemic of tuberculosis (TB) and HIV and on training a new generation of scientists in Africa.
Scientists at Albert Einstein College of Medicine of Yeshiva University have identified genetic markers that signal poor outcomes for patients with head and neck cancer. These findings could one day lead to a genetic test that could help select or predict successful treatment options for patients with this type of cancer.
Bacterial resistance to antibiotics is one of medicine's most vexing challenges. In a study described in Nature Chemical Biology, researchers from Albert Einstein College of Medicine of Yeshiva University are developing a new generation of antibiotic compounds that do not provoke bacterial resistance.
Women with certain gene variations appear to be protected against cervical cancer, according to a study led by scientists at Albert Einstein College of Medicine of Yeshiva University and reported in Clinical Cancer Research.
For the third time in 14 months, the Empire State Stem Cell Board has awarded Albert Einstein College of Medicine of Yeshiva University funding for stem cell research. The new grants, totaling $12.7 million, will help create technologies for treating sickle cell anemia, cancer, heart and liver disease, as well as obesity and hepatitis.
A prominent cancer researcher and surgeon from the National Cancer Institute, Steven Libutti, M.D., has been appointed professor and vice chair of surgery at Albert Einstein College of Medicine of Yeshiva University and at Montefiore Medical Center, the University Hospital and Academic Medical Center for Einstein.
Older adults who have impaired glucose tolerance but who are not considered diabetic are at elevated risk for heart disease and may benefit from preventive therapies, according to a new study conducted by researchers at Albert Einstein College of Medicine of Yeshiva University.
Four Albert Einstein College of Medicine faculty members were awarded a five-year, $10-million grant from the National Institutes of Health to study autophagy"“a fundamental cell process that may hold the key to aging.
A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating extensively drug resistant tuberculosis (XDR-TB), the most deadly form of the infection.
Women who have more years of fertility (the time from first menstruation to menopause) have a lower risk of developing Parkinson's disease than women with fewer years, according to a large, new study by researchers at Albert Einstein College of Medicine of Yeshiva University.
Bruce Rapkin, Ph.D., has been appointed director of the newly established Cancer Prevention and Control Research (CPCR) Program at Albert Einstein College of Medicine of Yeshiva University.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right